Zepbound

Zepbound is the brand name for injectable tirzepatide manufactured by Eli Lilly, FDA-approved specifically for chronic weight management in adults with obesity or overweight plus a related condition. It shares its active ingredient with Mounjaro, which is approved for type 2 diabetes.